Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infecte...

Por Yarchoan, R, Redfield, R R, Broder, S
Publicado em 1986

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia

Por Velasco, P, Dutcher, L, Davis, DA, Yarchoan, R
Publicado no Infect Agent Cancer (2009)

Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.

Por Yarchoan, R, Schneider, H S, Wray, B B, Nelson, D L
Publicado em 1983

Preferential depletion of a splenic marginal zone-like peripheral blood CD27+B220- memory B cell population in HIV-1 infected individuals

Por Morrow, M, Valentin, A, Little, R, Yarchoan, R, Pavlakis, GN
Publicado em 2006

Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells.

Por Yang, Y, Bailey, J, Vacchio, M S, Yarchoan, R, Ashwell, J D
Publicado em 1995

Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Por Yarchoan, R, Guo, H G, Reitz, M, Maluish, A, Mitsuya, H, Broder, S
Publicado em 1986

A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein

Por Sakakibara, S, Espigol-Frigole, G, Gasperini, P, Uldrick, TS, Yarchoan, R, Tosato, G
Publicado em 2012

Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearan...

Por Humphrey, R W, Ohagen, A, Davis, D A, Fukazawa, T, Hayashi, H, Höglund, S, Mitsuya, H, Yarchoan, R
Publicado em 1997

Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.

Por Blauvelt, A, Asada, H, Saville, M W, Klaus-Kovtun, V, Altman, D J, Yarchoan, R, Katz, S I
Publicado em 1997

Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.

Por Tosato, G, Steinberg, A D, Yarchoan, R, Heilman, C A, Pike, S E, De Seau, V, Blaese, R M
Publicado em 1984

Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.

Por Shirasaka, T, Yarchoan, R, O'Brien, M C, Husson, R N, Anderson, B D, Kojima, E, Shimada, T, Broder, S, Mitsuya, H
Publicado em 1993

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

Por Dunleavy, K, Little, RF, Wayne, AS, Grant, N, Pittaluga, S, Jaffe, ES, Steinberg, S, Yarchoan, R, Carrasquillo, J, Janik, J, Wilson, WH
Publicado no Infect Agent Cancer (2009)

Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.

Por Murphy, B R, Phelan, M A, Nelson, D L, Yarchoan, R, Tierney, E L, Alling, D W, Chanock, R M
Publicado em 1981

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

Por Shirasaka, T, Kavlick, M F, Ueno, T, Gao, W Y, Kojima, E, Alcaide, M L, Chokekijchai, S, Roy, B M, Arnold, E, Yarchoan, R
Publicado em 1995

K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine.

Por Gu, Z, Salomon, H, Cherrington, J M, Mulato, A S, Chen, M S, Yarchoan, R, Foli, A, Sogocio, K M, Wainberg, M A
Publicado em 1995

HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase.

Por Davis, D A, Newcomb, F M, Moskovitz, J, Wingfield, P T, Stahl, S J, Kaufman, J, Fales, H M, Levine, R L, Yarchoan, R
Publicado em 2000

Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)

Por Yarchoan, R, O'Mahony, D, Aleman, K, Wyvill, KM, Whitby, D, Bernstein, W, Pittaluga, S, Jaffe, ES, Tosato, G, Davis, DA, Steinberg, SM, Little, RF
Publicado no Infect Agent Cancer (2009)

Profiling viral and host microRNA expression in cells infected with KSHV and EBV

Por Yarchoan R, Little R, Ruscetti F, Kim CH, Skalsky RL, Hu J, HanJ S-J, Marshall V, Bagni R, Miley W, Whitby D, Renne R
Publicado em 2009-06-01

Profiling viral and host microRNA expression in cells infected with KSHV and EBV

Por Whitby, D, Miley, W, Bagni, R, Marshall, V, HanJ, S-J, Hu, J, Skalsky, RL, Kim, CH, Ruscetti, F, Little, R, Yarchoan, R, Renne, R
Publicado no Infect Agent Cancer (2009)

HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.

Por Stefanová, I, Saville, M W, Peters, C, Cleghorn, F R, Schwartz, D, Venzon, D J, Weinhold, K J, Jack, N, Bartholomew, C, Blattner, W A, Yarchoan, R, Bolen, J B, Horak, I D
Publicado em 1996